MrMrsMsDr
Interest *DemoCareersPartnershipResearch CollaborationOthers
Message
I have read and fully agree to the term of Consent to the Collection and Use of Personal Information. *
Media
News
Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology
Deep Bio and Roche Collaborate to Drive AI-Powered Innovations in Digital Pathology
ABION and Deep Bio Sign MOU to Advance AI-Driven Companion Diagnostics and Clinical Trials
Deep Bio’s AI Model for Prostate Cancer Assessment Validated by Researchers
Videos
Dr. Fouad Kettani’s Experience Using DeepDx Prostate: A Testimonial
Deep Bio Unveils Research Findings on Performance Evaluation of AI Algorithm for Breast Cancer Analysis
[BioSpectrum Asia] AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option
Deep Bio’s DeepDx Prostate Featured in CancerX’s Solutions Catalog, Pioneering Digital Innovation in Oncology
Deep Bio Announces Launch of DeepDx Prostate in Switzerland, Paving the Way for European Expansion
Deep Bio becomes first Korean cancer diagnostic AI company to win CES Innovation Award
Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise
Deep Bio Earns Coveted Spot in Korea AI Startup 100 List for the Third Consecutive Year
Deep Bio Welcomes Grant Carlson as Chief Commercial Officer
Deep Bio Secures Spot in South Korean Government’s Prestigious “Super Gap Startup 1000+” Program
Deep Bio’s AI Algorithm Helps Risk Stratification for Prostate Cancer
Publications
[Abstract] ASCO 2023 – Algorithm-based histologic grade and tumor ratio for radical prostatectomy: Comparison with pathology reports.
[Abstract] ASCO 2023 – Exploring the efficacy of a continuous form of the histologic grade in prostate cancer prognosis prediction
[Abstract] ASCO 2023 – Validation of AI-based postoperative nomograms for biochemical recurrence in prostate adenocarcinoma
[Abstract] ASCO 2023 – Deep learning-based histomorphological pattern profiles for effective risk stratification in prostate cancer.
[Posters] AACR 2023 – Clonal Evaluation of ERG/SPINK1 Status to Determine Disease Progression Using Whole Mount Prostatectomy Specimens
[Posters] AACR 2023 – Protein Receptor Prediction Model Using Only H&E Stained Images in Breast Cancer.
[Posters] USCAP 2023 – Evaluation of Attention-based Tumor Area Segmentation Deep Learning Models for c-MET Immunohistochemical Stained Non-small Cell Lung Cancer Slide Images
